Five Challenging Cases of Hereditary Antithrombin Deficiency Characterized by Thrombosis or Complicated Pregnancy

References

• Rodgers GM. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. Thromb Haemost. 2017;101(05):806–812. doi:10.1160/th08-10-0672
   Web of Science ®Google Scholar
• Levy JH, Sniecinski RM, Welsby IJ, Levi M. Antithrombin: anti-inflammatory properties and clinical applications. Thromb Haemost. 2016;115(4):712–728. doi:10.1160/TH15-08-0687
   PubMed Web of Science ®Google Scholar
• Roemisch J, Gray E, Hoffmann JN, Wiedermann CJ. Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis. 2002;13(8):657–670. doi:10.1097/00001721-200212000-00001
   PubMed Web of Science ®Google Scholar
• Kondo S, Kisiel W. Regulation of factor VIIa activity in plasma: evidence that antithrombin III is the sole plasma protease inhibitor of human factor VIIa. Thromb Res. 1987;46(2):325–335. doi:10.1016/0049-3848(87)90294-5
   PubMed Web of Science ®Google Scholar
• Broze GJ Jr, Likert K, Higuchi D. Inhibition of factor VIIa/tissue factor by antithrombin III and tissue factor pathway inhibitor. Blood. 1993;82(5):1679–1681. doi:10.1182/blood.V82.5.1679.1679
   PubMed Web of Science ®Google Scholar
• Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh. 1965;13:516–530.
   PubMedGoogle Scholar
• Martinelli I, Mannucci PM, De Stefano V, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood. 1998;92(7):2353–2358. doi:10.1182/blood.V92.7.2353
   PubMed Web of Science ®Google Scholar
• Bucciarelli P, Rosendaal FR, Tripodi A, et al. Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study. Arterioscler Thromb Vasc Biol. 1999;19(4):1026–1033. doi:10.1161/01.atv.19.4.1026
   PubMed Web of Science ®Google Scholar
• Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med. 2003;138(2):128–134. doi:10.7326/0003-4819-138-2-200301210-00014
   PubMed Web of Science ®Google Scholar
• Mannucci PM, Tripodi A, Mari D. Congenital deficiencies of anticoagulant proteins (antithrombin III and protein C). Haematologica. 1984;69(6):730–746.
   PubMed Web of Science ®Google Scholar
• Cooper PC, Coath F, Daly ME, Makris M. The phenotypic and genetic assessment of antithrombin deficiency. Int J Lab Hematol. 2011;33(3):227–237. doi:10.1111/j.1751-553X.2011.01307.x
   PubMed Web of Science ®Google Scholar
• Ishiguro K, Kojima T, Kadomatsu K, et al. Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest. 2000;106(7):873–878. doi:10.1172/JCI10489
   PubMed Web of Science ®Google Scholar
• Bravo-Perez C, Vicente V, Corral J. Management of antithrombin deficiency: an update for clinicians. Expert Rev Hematol. 2019;12(6):397–405. doi:10.1080/17474086.2019.1611424
   PubMed Web of Science ®Google Scholar
• Lane DA, Caso R. 9 Antithrombin: structure, genomic organization, function and inherited deficiency. Baillières Clin Haematol. 1989;2(4):961–998. doi:10.1016/S0950-3536(89)80054-X
   PubMedGoogle Scholar
• Luxembourg B, Delev D, Geisen C, et al. Molecular basis of antithrombin deficiency. Thromb Haemost. 2011;105(4):635–646. doi:10.1160/TH10-08-0538
   PubMed Web of Science ®Google Scholar
• van Boven HH, Lane DA. Antithrombin and its inherited deficiency states. Semin Hematol. 1997;34(3):188–204.
   PubMed Web of Science ®Google Scholar
• Tarantino MD, Curtis SM, Johnson GS, Waye JS, Blajchman MA. A novel and de novo spontaneous point mutation (Glu271STOP) of the antithrombin gene results in a type I deficiency and thrombophilia. Am J Hematol. 1999;60(2):126–129. doi:10.1002/(sici)1096-8652(199902)60:2<126::aid-ajh7>3.0.co;2-l
   PubMed Web of Science ®Google Scholar
• Committee on Obstetric Practice: American College of Obstetricians and Gynecologists AAoP-CoFaN. The Apgar Score. American College of Obstetricians and Gynecologists; 2021. Available from: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2015/10/the-apgar-score. Accessed May 17, 2021.
   Google Scholar
• Tait RC, Walker ID, Perry DJ, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol. 1994;87(1):106–112. doi:10.1111/j.1365-2141.1994.tb04878.x
   PubMed Web of Science ®Google Scholar
• Wells PS, Blajchman MA, Henderson P, et al. Prevalence of antithrombin deficiency in healthy blood donors: a cross-sectional study. Am J Hematol. 1994;45(4):321–324. doi:10.1002/ajh.2830450409
   PubMed Web of Science ®Google Scholar
• Patnaik MM, Moll S. Inherited antithrombin deficiency: a review. Haemophilia. 2008;14(6):1229–1239. doi:10.1111/j.1365-2516.2008.01830.x
   PubMed Web of Science ®Google Scholar
• Lane DA, Bayston T, Olds RJ, et al. Antithrombin mutation database: 2nd (1997) update. For the plasma coagulation inhibitors subcommittee of the scientific and standardization committee of the international society on thrombosis and haemostasis. Thromb Haemost. 1997;77(1):197–211. doi:10.1055/s-0038-1655930
   PubMed Web of Science ®Google Scholar
• Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585. doi:10.1001/archinte.158.6.585
   PubMed Web of Science ®Google Scholar
• Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151(5):933–938. doi:10.1001/archinte.1991.00400050081016
   PubMedGoogle Scholar
• Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):3–14. doi:10.1007/s11239-015-1311-6
   PubMed Web of Science ®Google Scholar
• Skelley JW, White CW, Thomason AR. The use of direct oral anticoagulants in inherited thrombophilia. J Thromb Thrombolysis. 2017;43(1):24–30. doi:10.1007/s11239-016-1428-2
   PubMed Web of Science ®Google Scholar
• Valanejad SM, Davis KA. Direct oral anticoagulants in select patients with hypercoagulable disorders. Ann Pharmacother. 2021;55(7):891–901. doi:10.1177/1060028020968551
   PubMed Web of Science ®Google Scholar
• Barsoum MK, Heit JA, Ashrani AA, Leibson CL, Petterson TM, Bailey KR. Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study. Thromb Res. 2010;126(5):373–378. doi:10.1016/j.thromres.2010.08.010
   PubMed Web of Science ®Google Scholar
• Khan F, Vaillancourt C, Bourjeily G. Diagnosis and management of deep vein thrombosis in pregnancy. BMJ. 2017;357:j2344. doi:10.1136/bmj.j2344
   PubMed Web of Science ®Google Scholar
• Nair M, Knight M. Chapter 2. Maternal mortality in the UK 2011–13: surveillance and epidemiology. In: Saving Lives, Improving Mothers’ Care - Surveillance of Maternal Deaths in the UK 2011–13 and Lessons Learned to Inform Maternity Care Form the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009–2013; 2015.
   Google Scholar
• Greer IA, Solomon CG. Clinical practice: pregnancy complicated by venous thrombosis. N Engl J Med. 2015;373(6):540–547. doi:10.1056/NEJMcp1407434
   PubMed Web of Science ®Google Scholar
• Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2(22):3317–3359. doi:10.1182/bloodadvances.2018024802
   PubMed Web of Science ®Google Scholar
• Kovac M, Mitic G, Mikovic Z, et al. The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications. Thromb Res. 2019;173:12–19. doi:10.1016/j.thromres.2018.11.006
   PubMed Web of Science ®Google Scholar
• Abbattista M, Gianniello F, Novembrino C, et al. Risk of pregnancy-related venous thromboembolism and obstetrical complications in women with inherited type I antithrombin deficiency: a retrospective, single-centre, cohort study. Lancet Haematol. 2020;7(4):e320–e328. doi:10.1016/S2352-3026(20)30007-7
   PubMed Web of Science ®Google Scholar
• Gindele R, Selmeczi A, Olah Z, et al. Clinical and laboratory characteristics of antithrombin deficiencies: a large cohort study from a single diagnostic center. Thromb Res. 2017;160:119–128. doi:10.1016/j.thromres.2017.10.023
   PubMed Web of Science ®Google Scholar